Načítá se...
Efficacy of a Once‐Daily Formulation of Carvedilol for the Treatment of Hypertension
β‐Blockers with pharmacologic effects that differ from conventional agents might add to antihypertensive treatment options. This study evaluated a new once‐daily formulation of the β‐/α(1)‐blocker, carvedilol controlled‐release (CR), in hypertensive patients off treatment or while still taking up to...
Uloženo v:
| Vydáno v: | J Clin Hypertens (Greenwich) |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Le Jacq Ltd.
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109495/ https://ncbi.nlm.nih.gov/pubmed/17170609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2006.05696.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|